Novo Nordisk Aktie
59,12
EUR
-1,76
EUR
-2,89
%
59,42
EUR
-0,58
EUR
-0,97
%
Werbung
Novo Nordisk Aktie Analyse
12.05.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
06.05.21 | Novo Nordisk Neutral | Credit Suisse Group | |
06.05.21 | Novo Nordisk buy | Deutsche Bank AG | |
06.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.05.21 | Novo Nordisk overweight | Barclays Capital | |
05.05.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.05.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
Werbung
|
|||
28.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
14.04.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
13.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
25.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
23.03.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
23.03.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
05.03.21 | Novo Nordisk buy | Deutsche Bank AG | |
04.03.21 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
18.02.21 | Novo Nordisk Neutral | UBS AG | |
16.02.21 | Novo Nordisk buy | Deutsche Bank AG | |
11.02.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
10.02.21 | Novo Nordisk buy | Deutsche Bank AG | |
09.02.21 | Novo Nordisk buy | Deutsche Bank AG | |
08.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
04.02.21 | Novo Nordisk overweight | Barclays Capital | |
04.02.21 | Novo Nordisk Neutral | Credit Suisse Group | |
04.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.02.21 | Novo Nordisk Outperform | Bernstein Research | |
03.02.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.02.21 | Novo Nordisk Neutral | UBS AG | |
03.02.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
26.01.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
26.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
20.01.21 | Novo Nordisk Neutral | Credit Suisse Group | |
20.01.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
18.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
15.01.21 | Novo Nordisk buy | Deutsche Bank AG | |
04.01.21 | Novo Nordisk kaufen | JP Morgan Chase & Co. | |
17.12.20 | Novo Nordisk Neutral | UBS AG | |
01.12.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.11.20 | Novo Nordisk Neutral | UBS AG | |
09.11.20 | Novo Nordisk Underweight | Morgan Stanley | |
06.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.11.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.11.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.11.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
02.11.20 | Novo Nordisk Neutral | UBS AG | |
02.11.20 | Novo Nordisk Outperform | Credit Suisse Group | |
30.10.20 | Novo Nordisk kaufen | Bernstein Research |
Werbung
Werbung